Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medifast Inc (MED)

Medifast Inc (MED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,342,461
  • Shares Outstanding, K 11,615
  • Annual Sales, $ 501,000 K
  • Annual Income, $ 55,790 K
  • 60-Month Beta 0.73
  • Price/Sales 2.03
  • Price/Cash Flow 23.00
  • Price/Book 12.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.07
  • Number of Estimates 2
  • High Estimate 1.08
  • Low Estimate 1.06
  • Prior Year 1.30
  • Growth Rate Est. (year over year) -17.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.81 +25.89%
on 12/18/19
117.89 -1.96%
on 01/15/20
+21.79 (+23.23%)
since 12/17/19
3-Month
66.50 +73.80%
on 11/08/19
117.89 -1.96%
on 01/15/20
+12.70 (+12.34%)
since 10/17/19
52-Week
66.50 +73.80%
on 11/08/19
159.41 -27.50%
on 05/02/19
-4.72 (-3.92%)
since 01/17/19

Most Recent Stories

More News
36.1% Return Seen to Date on SmarTrend Medifast Inc Call (MED)

SmarTrend identified an Uptrend for Medifast Inc (NYSE:MED) on November 20th, 2019 at $85.73. In approximately 2 months, Medifast Inc has returned 36.10% as of today's recent price of $116.68.

MED : 115.58 (-1.12%)
The Extreme Risks of Trading Your Own Retirement Assets - January 14, 2020

Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.

MED : 115.58 (-1.12%)
ABBV : 88.00 (-1.41%)
MPX : 14.23 (+2.74%)
Watch for Medifast Inc to Potentially Pullback After Gaining 3.33% Yesterday

Medifast Inc (NYSE:MED) traded in a range yesterday that spanned from a low of $113.90 to a high of $116.47. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $113.56...

MED : 115.58 (-1.12%)
Powerful Proof Anyone Can Invest for an Early Retirement - January 13, 2020

Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices,...

FFIC : 20.96 (-1.04%)
MED : 115.58 (-1.12%)
MPX : 14.23 (+2.74%)
Medifast Inc Shares Up 30.1% Since SmarTrend's Buy Recommendation (MED)

SmarTrend identified an Uptrend for Medifast Inc (NYSE:MED) on November 20th, 2019 at $85.73. In approximately 2 months, Medifast Inc has returned 30.14% as of today's recent price of $111.56.

MED : 115.58 (-1.12%)
Medifast, Inc. to Present at the 22nd Annual ICR Conference

Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformation, One Healthy Habit at a Time®, announced today...

MED : 115.58 (-1.12%)
Medifast Inc Up 25.6% Since SmarTrend Uptrend Call (MED)

SmarTrend identified an Uptrend for Medifast Inc (NYSE:MED) on November 20th, 2019 at $85.73. In approximately 1 month, Medifast Inc has returned 25.63% as of today's recent price of $107.70.

MED : 115.58 (-1.12%)
America's Car Mart, Medifast, Microsoft, Apple and Amazon highlighted as Zacks Bull and Bear of the Day

America's Car Mart, Medifast, Microsoft, Apple and Amazon highlighted as Zacks Bull and Bear of the Day

CRMT : 109.55 (-0.45%)
AMZN : 1,864.72 (-0.70%)
AAPL : 318.73 (+1.11%)
MSFT : 167.10 (+0.56%)
MED : 115.58 (-1.12%)
Bear of the Day: Medifast (MED)

Bear of the Day: Medifast (MED)

MED : 115.58 (-1.12%)
Noteworthy Tuesday Option Activity: MED, AYI, TELL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Medifast Inc , where a total of 2,131 contracts have traded so far, representing approximately...

MED : 115.58 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MED with:

Business Summary

Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, distributes, and sells weight loss and other health-related products through websites, multi-level marketing, telemarketing,...

See More

Key Turning Points

2nd Resistance Point 119.47
1st Resistance Point 117.53
Last Price 115.58
1st Support Level 113.90
2nd Support Level 112.21

See More

52-Week High 159.41
Fibonacci 61.8% 123.92
Last Price 115.58
Fibonacci 50% 112.96
Fibonacci 38.2% 101.99
52-Week Low 66.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar